Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12476
CALL
Ennis
EBF
$559M
| $44.3K | ﹤0.01% |
2,100
+700
| +50% | +$15K |
|
12477
Solitario Resources
XPL
$75.7M
| $44.3K | ﹤0.01% |
74,498
-10,615
| -12% | -$6.77K |
|
12478
PUT
Turkcell
TKC
$4.75B
| $44.3K | ﹤0.01% |
+6,800
| New | +$44.2K |
|
|
TEF
12479
CALL
DELISTED
Telefonica
TEF
| $44.2K | ﹤0.01% |
11,000
+900
| +9% | +$4.05K |
|
12480
CALL
Dimensional US Real Estate ETF
DFAR
$1.79B
| $44.2K | ﹤0.01% |
+1,900
| New | +$47K |
|
12481
InnovAge Holding
INNV
$1.44B
| $44.2K | ﹤0.01% |
+11,246
| New | +$58.2K |
|
12482
CALL
Regional Management Corp
RM
$309M
| $44.2K | ﹤0.01% |
1,300
+1,100
| +550% | +$34.5K |
|
|
STR
12483
PUT
DELISTED
Sitio Royalties
STR
| $44.1K | ﹤0.01% |
2,300
| – | – |
|
12484
CALL
Xeris Biopharma Holdings
XERS
$1.57B
| $44.1K | ﹤0.01% |
13,000
-83,500
| -87% | -$269K |
|
12485
PUT
ProShares UltraShort FTSE Europe
EPV
$10.2M
| $44K | ﹤0.01% |
+1,060
| New | +$40.8K |
|
|
USAP
12486
PUT
DELISTED
Universal Stainless & Alloy
USAP
| $44K | ﹤0.01% |
1,000
-2,900
| -74% | -$125K |
|
12487
PUT
Cemex
CX
$16B
| $44K | ﹤0.01% |
7,800
-18,300
| -70% | -$104K |
|
12488
PUT
Direxion Daily Industrials Bull 3X ETF
DUSL
$62.7M
| $44K | ﹤0.01% |
800
+300
| +60% | +$19.9K |
|
12489
Marchex
MCHX
$82M
| $44K | ﹤0.01% |
25,130
+16,623
| +195% | +$30.7K |
|
|
VXRT
12490
CALL
DELISTED
Vaxart
VXRT
| $44K | ﹤0.01% |
66,400
+600
| +0.9% | +$417 |
|
|
SEMR
12491
PUT
DELISTED
Semrush
SEMR
| $44K | ﹤0.01% |
3,700
-17,000
| -82% | -$228K |
|
|
ONTF
12492
CALL
DELISTED
ON24
ONTF
| $43.9K | ﹤0.01% |
6,800
-7,900
| -54% | -$50.7K |
|
12493
PUT
Gentherm
THRM
$1.35B
| $43.9K | ﹤0.01% |
1,100
-9,700
| -90% | -$407K |
|
|
YMAB
12494
CALL
DELISTED
Y-mAbs Therapeutics
YMAB
| $43.8K | ﹤0.01% |
5,600
-14,700
| -72% | -$179K |
|
|
HTT
12495
High Templar Tech Ltd
HTT
$393M
| $43.8K | ﹤0.01% |
15,548
-388,791
| -96% | -$980K |
|
12496
CALL
Nkarta
NKTX
$167M
| $43.8K | ﹤0.01% |
17,600
-35,900
| -67% | -$111K |
|
12497
CALL
The ONE Group
STKS
$57.8M
| $43.8K | ﹤0.01% |
15,100
+15,000
| +15,000% | +$49.8K |
|
|
AKYA
12498
DELISTED
Akoya BioSciences
AKYA
| $43.6K | ﹤0.01% |
19,044
-32,754
| -63% | -$86.8K |
|
|
ACRE
12499
PUT
Ares Commercial Real Estate
ACRE
$262M
| $43.6K | ﹤0.01% |
7,400
-4,100
| -36% | -$27.6K |
|
12500
PUT
SI-BONE Inc
SIBN
$848M
| $43.5K | ﹤0.01% |
3,100
+1,400
| +82% | +$18.8K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.